Premium
Phase Angle as a Sarcopenia Marker in Hospitalized Elderly Patients
Author(s) -
Santatalia de Moraes,
Pinho Claudia Porto Sabino,
da Silva Cristiane Pereira,
dos Santos Natalia Fernandes,
Mendes Roberta Maria Lins
Publication year - 2018
Publication title -
nutrition in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 71
eISSN - 1941-2452
pISSN - 0884-5336
DOI - 10.1002/ncp.10016
Subject(s) - sarcopenia , medicine , bioelectrical impedance analysis , muscle mass , predictive value , body mass index
Background Phase angle (PhA) has been proposed as a parameter to predict clinical outcomes and mortality for various diseases. Several studies have considered it an important nutrition assessment tool. However, the usefulness of this parameter as a sarcopenia marker has not yet been evaluated. This study was developed to evaluate the performance of PhA as a sarcopenia marker in hospitalized elderly patients. Materials and Methods This was a cross‐sectional study involving elderly patients admitted to a hospital in northeastern Brazil. The PhA was obtained from resistance and reactance measurements by bioelectrical impedance. Sarcopenia was defined as a decrease in muscle mass associated with a reduced muscle strength or physical performance. Results The sample consisted of 148 patients with a mean age of 71.6 (±7.6) years and a 62.8% prevalence of sarcopenia. The average PhA was 5.9 ± 2.0°, similar for men and women (5.9 ± 2.3 vs 5.9 ± 1.8; P = .946). In men, sarcopenic patients had a lower average PhA (5.6 ± 2.3°) when compared with patients without this condition (6.8 ± 1.9°; P = .024). When comparing the value of PhA regarding the degree of sarcopenia, it was found that patients from both sexes with severe sarcopenia had lower averages. The PhA had a low predictive capacity in relation to the diagnostic components of sarcopenia (physical performance, muscle mass, and strength). Conclusion PhA was an inaccurate marker to identify sarcopenia and presented low predictive capacity to explain muscle mass, muscle strength, and functional capacity, components involved in the diagnosis of sarcopenia.